Mill Road Capital Management LLC Makes New $1.40 Million Investment in ZimVie Inc. (NASDAQ:ZIMV)

Mill Road Capital Management LLC purchased a new stake in ZimVie Inc. (NASDAQ:ZIMV - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund purchased 100,453 shares of the company's stock, valued at approximately $1,401,000. ZimVie makes up about 0.7% of Mill Road Capital Management LLC's investment portfolio, making the stock its 21st largest holding. Mill Road Capital Management LLC owned 0.36% of ZimVie as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Barclays PLC raised its holdings in shares of ZimVie by 338.4% in the 3rd quarter. Barclays PLC now owns 43,437 shares of the company's stock worth $690,000 after acquiring an additional 33,529 shares during the last quarter. Geode Capital Management LLC raised its holdings in shares of ZimVie by 2.4% in the 3rd quarter. Geode Capital Management LLC now owns 646,564 shares of the company's stock worth $10,263,000 after acquiring an additional 15,053 shares during the last quarter. Principal Financial Group Inc. acquired a new stake in shares of ZimVie in the 3rd quarter worth about $275,000. JPMorgan Chase & Co. raised its holdings in shares of ZimVie by 66.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 183,419 shares of the company's stock worth $2,911,000 after acquiring an additional 73,395 shares during the last quarter. Finally, Monarch Capital Management Inc. raised its holdings in shares of ZimVie by 6.2% in the 4th quarter. Monarch Capital Management Inc. now owns 65,560 shares of the company's stock worth $915,000 after acquiring an additional 3,847 shares during the last quarter. 95.63% of the stock is owned by institutional investors.

ZimVie Stock Performance

Shares of NASDAQ ZIMV traded down $0.13 during mid-day trading on Monday, hitting $9.31. The company had a trading volume of 81,678 shares, compared to its average volume of 221,960. The company has a market capitalization of $259.26 million, a price-to-earnings ratio of -0.71 and a beta of 2.14. ZimVie Inc. has a 1 year low of $8.56 and a 1 year high of $22.40. The company has a current ratio of 1.94, a quick ratio of 1.38 and a debt-to-equity ratio of 0.57. The stock's 50-day moving average price is $11.16 and its 200-day moving average price is $13.03.

ZimVie (NASDAQ:ZIMV - Get Free Report) last posted its earnings results on Wednesday, February 26th. The company reported $0.27 EPS for the quarter, topping the consensus estimate of $0.25 by $0.02. ZimVie had a positive return on equity of 2.90% and a negative net margin of 77.31%. The business had revenue of $111.52 million during the quarter, compared to analysts' expectations of $113.67 million. On average, sell-side analysts forecast that ZimVie Inc. will post 0.6 earnings per share for the current year.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on the stock. Needham & Company LLC restated a "hold" rating on shares of ZimVie in a report on Wednesday, April 9th. B. Riley started coverage on ZimVie in a research report on Thursday, April 10th. They issued a "buy" rating and a $16.00 target price for the company.

ZimVie Profile

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.